You are here: Industry Insights > Cancer

News List

CRISPR and Massachusetts General Hospital partner to develop T-cell therapies pharmaceutical-technology
August 25, 2017
CRISPR Therapeutics has entered a new research collaboration and licence option agreement with Massachusetts General Hospital Cancer Centre (MGHCC) to develop new T-cell therapies for cancer.
Choosing alternative cancer treatment doubles the risk of death: New Research biospectrumasia
August 25, 2017
people who took alternative medicine were two and half times more likely to die within five years of diagnosis
Cancer Research UK launches trial to test new drug europeanpharmaceuticalreview
August 24, 2017
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK today…
Cancer Genetics acquires vivoPharm for $12 million USD biospectrumasia
August 23, 2017
This transaction will significantly strengthen CGI's position as a premier leader for oncology discovery, in vivo and in vitro drug development and early phase clinical trial testing for biotechnology and pharmaceutical companies
New personalised molecular blood test could shake up cancer treatment pharmafile
August 17, 2017
A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer
NICE approves three quarters of the Cancer Drugs Fund europeanpharmaceuticalreview
August 15, 2017
NICE has recommended sorafenib to be routinely available for patients on the NHS making it one of the 24 drugs appraised from the CDF…
Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments pharmaceutical-technology
August 15, 2017
Takeda Pharmaceutical has entered a research collaboration with Shattuck Labs to study and develop checkpoint fusion proteins that have the potential to be used as highly differentiated, advanced immunotherapies for cancer.
Biotech to drive biggest cancer advancements in decades – report pharmatimes
August 11, 2017
A new report on the prospects of immunotherapy treatments has identified smaller, nimble biotechs and early stage companies as the single biggest factor behind the next generation of approaches in development.
Cancer Research UK and Biotecnol to trial new immunotherapy pharmatimes
August 11, 2017
A new collaboration agreement between Cancer Research UK and Biotecnol will see an experimental immuno-oncology treatment move into early phase clinical trials for patients with advanced solid tumours, including lung cancers.
WuXi AppTec promotes prospects of immunotherapy biospectrumasia
August 11, 2017
Over the next 10-years, we will see significantly greater breakthroughs as the industry’s understanding of the immune system improves.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page